Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
8.14
-0.48 (-5.57%)
Mar 31, 2025, 10:48 AM EDT - Market open
Wave Life Sciences Employees
As of December 31, 2024, Wave Life Sciences had 288 total employees, including 287 full-time and 1 part-time employees. The number of employees increased by 20 or 7.46% compared to the previous year.
Employees
288
Change (1Y)
20
Growth (1Y)
7.46%
Revenue / Employee
$376,049
Profits / Employee
-$336,833
Market Cap
1.25B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
WVE News
- 3 days ago - Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531 - Seeking Alpha
- 5 days ago - Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year - Benzinga
- 5 days ago - Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 - GlobeNewsWire
- 26 days ago - Wave Life Sciences Ltd. (WVE) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 - GlobeNewsWire
- 7 weeks ago - Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity - GlobeNewsWire
- 2 months ago - Wave Life Sciences Is A Buy On Pipeline Prospects - Seeking Alpha